US FDA approves Bharat Biotech’s Covaxin for clinical trails
The US Food and Drug Administration has lifted the clinical hold on Bharat Biotech's Covaxin.
Bharat BioTech’s Covaxin
Stay updated with the latest news and articles about Bharat BioTech’s Covaxin.
Latest Articles
USA to allow travellers vaccinated with Covaxin
From November 8, the United States will allow passengers who have been vaccinated with Covaxin to enter the country.
Bharat Biotech is waiting for WHO’s feedback on Covaxin for Emergency Use Listing
Bharat Biotech recently stated it has submitted all of the information bearings on its COVID-19 vaccine Covaxin to the World health organization (WHO) for Emergency Use Listing (EUL) and is anticipating feedback.
Bharat Biotech’s COVAXIN gets GMP certificate from Hungarian authority
Bharat Biotech owned COVID-19 vaccine, Covaxin accrued Good Manufacturing Practice certification from the Hungarian administration, this Thursday.
Covaxin phase 3 drug trial approved by SEC
The COVAXIN is an inactive vaccine that is developed by chemically treating the novel coronavirus samples to make it incapable of reproduction. That process leave the viral proteins intact, also including the spike protein of the coronavirus which it uses to enter the human cells.
Union Health Ministry rejects media claims of ‘not placing’ fresh orders of COVID-19 vaccine
Ministry of Health issued a statement denying media reports of not placing any fresh order for Covid vaccines since March 2021. While the ministry declares that the allegations are a pile of complete rubbish.
Showing 15 of 16 articles